health π¦ Bacteria are beating our meds, docs get new guide
The Infectious Diseases Society of America issued an updated playbook for hard-to-treat bacterial infections. This change is due to a sharp rise in resistance genes disabling last-resort antibiotics, especially in hospitals. Between 2016 and 2023, the blaNDM gene share in CRE rose from 5.4 percent to 39.8 percent. The new guidance incorporates specific drugs for NDM-producing infections, like aztreonam-avibactam. However, these new treatments only work if labs correctly identify the specific resistance enzyme. π¦